Nanosilver is widely used in medicine, industry, and other applications where it poses a high potential risk for human health, even though little information is available on its toxicity to vital organs. This study was conducted to determine the histopathological changes induced in renal tissues by various sizes of silver nanoparticles (SNPs). Male BALB/C mice were exposed to various sizes of SNPs for 5 weeks. Renal tissue samples from all members of all experimental groups were subjected to histological processing and histopathological examination. SNPs caused glomerular and tubular alterations in the form of tubular degeneration, necrosis, eosinophilia, glomerular shrinkage, and Bowman's capsule thickening. Moreover, SNPs induced interstitial intertubular regeneration, mononuclear inflammatory cell infiltration, proteinaceous casting, and fibrocyte proliferation. These results indicated that smaller particles (10 and 20 nm) were more toxic than the larger ones (40, 60, and 100 nm). In addition, the cortex was more affected than the medulla, and the proximal tubules were more affected than the distal ones. The results of the current investigation reveal that SNPs induce histomorphological alterations in renal tissues, with size being a key factor in the toxicity of these particles.

References

1. 1)
  - 12. Austin, C.A., Umbreit, T.H., Brown, K.M., et al: ‘Distribution of silver nanoparticles in pregnant mice and developing embryos’, Nanotoxicology, 2011, 6, pp. 912–922 (doi: 10.3109/17435390.2011.626539).
2. 2)
  - 15. Jarrar, B.M., Taib, N.: ‘Histocytotechnology’ (King Saud University Press, Riyadh, 2008, 3th edn.).
3. 3)
  - 1. Luoma, S.N.: ‘Silver nanoparticles and the environment: old problems or new challenges?’, Project on Emerging Nanotechnology. Woodrow Wilson International Center for Scholars, The PEW Charitable Trust. Publication PEN 15, 2008.
4. 4)
  - 8. Rosenkranz, P.W.: ‘The ecotoxicology of nanoparticles in Daphnia magna’, Presented for PhD, Edinburgh Napier University, Edinburgh, 2010.
5. 5)
  - 13. Kim, Y.S., Song, M.Y., Park, J.D., et al: ‘Subchronic oral toxicity of silver nanoparticles’, Part. Fibre Toxicol., 2010, 7, pp. 20–20 (doi: 10.1186/1743-8977-7-20).
6. 6)
  - 3. Hanson, J.: ‘Nano silver legal petition: 300 nano silver products’ (International Center for Technology Assessment, Washington DC, 2011).
7. 7)
  - 25. Duran, N., Silveira, C.P., Duran, M., et al: ‘Silver nanoparticle protein corona and toxicity: a mini-review’, J. Nanobiotechnol., 2015, 13, p. 55 (doi: 10.1186/s12951-015-0114-4).
8. 8)
  - 6. Iravani, S., Korbekandi, H., Mirmohammadi, S.V., et al: ‘Synthesis of silver nanoparticles: chemical, physical and biological methods’, Res. Pharm. Sci., 2014, 9, (6), pp. 385–406.
9. 9)
  - 5. Jiang, Z., Yuan, W., Pan, H.: ‘Luminescence effect of silver nanoparticle in water phase’, Spectrochim. Acta A, 2005, 61, (11-12), pp. 2488–2494 (doi: 10.1016/j.saa.2004.09.014).
10. 10)
  - 10. Jain, J., Arora, S., Rajwade, J.M., Omray, P., Khandelwal, S., Paknikar, K.M.: ‘Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use’, Mol. Pharmaceutics, 2009, 6, pp. 1388–1401 (doi: 10.1021/mp900056g).
11. 11)
  - 24. Pryor, W.A., Stone, K.: ‘Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite’, Ann. New York Acad. Sci., 1993, 686, pp. 12–28 (doi: 10.1111/j.1749-6632.1993.tb39148.x).
12. 12)
  - 21. Seki, J., Sonoke, S., Saheki, A., et al: ‘A nanometer lipid emulsion, lipid nano-sphere (LNS), as a parenteral drug carrier for passive drug targeting’, Int. J. Pharm., 2004, 273, pp. 75–83 (doi: 10.1016/j.ijpharm.2003.12.022).
13. 13)
  - 16. Hayat, M.A.: ‘Principles and techniques of electron microscopy, biological applications’ (Cambridge University Press, Cambridge, UK, 2000, 4th edn.).
14. 14)
  - 14. Park, E.J., Bae, E., Yi, J., et al: ‘Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles’, Environ. Toxicol. Pharmacol., 2010, 30, (2), pp. 162–168 (doi: 10.1016/j.etap.2010.05.004).
15. 15)
  - 18. Pineda, L., Chwalibog, A., Sawosz, E., et al: ‘Effect of silver nanoparticles on growth performance, metabolism and microbial profile of broiler chickens’, Arch. Animal Nutr., 2012, 66, (5), pp. 416–429 (doi: 10.1080/1745039X.2012.710081).
16. 16)
  - 9. Yu, M.K., Park, J., Jon, S.: ‘Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy’, Theranostics, 2012, 2, (1), pp. 3–44 (doi: 10.7150/thno.3463).
17. 17)
  - 17. Kalantzi, O.I., Biskos, G.: ‘Methods for assessing basic particle properties and cytotoxicity of engineered nanoparticles’, Toxics, 2014, 2, pp. 79–91 (doi: 10.3390/toxics2010079).
18. 18)
  - 20. Johar, D., Roth, J.C., Bay, G.H., et al: ‘Inflammatory response, reactive oxygen species, programmed (necrotic-like and apoptotic) cell death and cancer’, Rocz. Akad. Med. Bialymst., 2004, 49, pp. 31–39.
19. 19)
  - 7. De Lima, R., Seabra, A.B., Durán, N.: ‘Silver nanoparticles: a brief review of cytotoxicity and genotoxicity of chemically and biogenically synthesized nanoparticles’, J. Appl. Toxicol., 2012, 32, (11), pp. 867–879 (doi: 10.1002/jat.2780).
20. 20)
  - 23. Liu, J., Hurt, R.H.: ‘Ion release kinetics and particle persistence in aqueous non-silver colloids’, Environ. Sci. Technol., 2010, 44, pp. 2169–2175 (doi: 10.1021/es9035557).
21. 21)
  - 11. Schrand, A.M., Bradich-Stolle, L.K., Schlager, J.J., et al: ‘Can silver nanoparticles be useful as potential biological labels?’, Nanotechnology, 2008, 19, pp. 1–13 (doi: 10.1088/0957-4484/19/23/235104).
22. 22)
  - 19. Jarrar, Q., Battah, A., Obeidat, F., et al: ‘Biochemical changes induced by the toxicity of variable sizes of silver nanoparticles’, Br. J. Pharmacol. Res., 2014, 4, (24), pp. 2670–2678 (doi: 10.9734/BJPR/2014/14666).
23. 23)
  - 4. Ahamed, M., Alsalhi, M.S., Siddiqui, M.K.: ‘Silver nanoparticle applications and human health’, Clin. Chim. Acta, 2010, 411, (23-24), pp. 1841–1848 (doi: 10.1016/j.cca.2010.08.016).
24. 24)
  - 25. Nel, A.E., Mädler, L., Velegol, D., et al: ‘Understanding biophysicochemical interactions at the nano–bio interface’, Nat. Mater., 2009, 8, pp. 543–557 (doi: 10.1038/nmat2442).
25. 25)
  - 10. Ma, R.C., Levard, C., Marinakos, S.M., et al: ‘Size-controlled dissolution of organic-coated silver nanoparticles’, Environ. Sci. Technol., 2012, 46, pp. 752–759 (doi: 10.1021/es201686j).

Renal histopathological alterations induced by nanosilver toxicity: the size effect

References

Related content